Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuele Ambrosini

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Cardiology|September 19, 2021
Molecular underpinnings of myocardial stiffness in patients with hypertrophic cardiomyopathyFlorian A Wenzl, Samuele Ambrosini, Francesco Paneni
Minerva Cardiology and Angiology|September 30, 2020
Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicineSamuele Ambrosini, Shafeeq A Mohammed, Sarah Costantino, et al.
Vascular Biology (Bristol, England)|September 14, 2020
The vascular epigenome in patients with obesity and type 2 diabetes: opportunities for personalized therapiesSarah Costantino, Shafeeq A Mohammed, Samuele Ambrosini, et al.
Atherosclerosis|October 7, 2018
Epigenetic processing in cardiometabolic diseaseSarah Costantino, Shafeeq A Mohammed, Samuele Ambrosini, et al.
Frontiers in Cardiovascular Medicine|March 21, 2020
Epigenetic Control of Mitochondrial Function in the VasculatureShafeeq A Mohammed, Samuele Ambrosini, Thomas Lüscher, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|August 3, 2020
New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on EpigeneticsSamuele Ambrosini, Shafeeq A Mohammed, Thomas F Lüscher, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Epi-Drugs in Heart FailureEra Gorica, Shafeeq A Mohammed, Samuele Ambrosini, et al.
Current Opinion in Cardiology|March 11, 2022
Epigenetic remodeling in heart failure with preserved ejection fractionSamuele Ambrosini, Era Gorica, Shafeeq A Mohammed, et al.
Frontiers in Cardiovascular Medicine|October 11, 2021
Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative StateGeorgios Louloudis, Samuele Ambrosini, Francesco Paneni, et al.
Frontiers in Cardiovascular Medicine|January 31, 2022
Corrigendum: Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative StateGeorgios Louloudis, Samuele Ambrosini, Francesco Paneni, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Cardiology|September 19, 2021
Molecular underpinnings of myocardial stiffness in patients with hypertrophic cardiomyopathyFlorian A Wenzl, Samuele Ambrosini, Francesco Paneni
Minerva Cardiology and Angiology|September 30, 2020
Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicineSamuele Ambrosini, Shafeeq A Mohammed, Sarah Costantino, et al.
Vascular Biology (Bristol, England)|September 14, 2020
The vascular epigenome in patients with obesity and type 2 diabetes: opportunities for personalized therapiesSarah Costantino, Shafeeq A Mohammed, Samuele Ambrosini, et al.
Atherosclerosis|October 7, 2018
Epigenetic processing in cardiometabolic diseaseSarah Costantino, Shafeeq A Mohammed, Samuele Ambrosini, et al.
Frontiers in Cardiovascular Medicine|March 21, 2020
Epigenetic Control of Mitochondrial Function in the VasculatureShafeeq A Mohammed, Samuele Ambrosini, Thomas Lüscher, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|August 3, 2020
New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on EpigeneticsSamuele Ambrosini, Shafeeq A Mohammed, Thomas F Lüscher, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Epi-Drugs in Heart FailureEra Gorica, Shafeeq A Mohammed, Samuele Ambrosini, et al.
Current Opinion in Cardiology|March 11, 2022
Epigenetic remodeling in heart failure with preserved ejection fractionSamuele Ambrosini, Era Gorica, Shafeeq A Mohammed, et al.
Frontiers in Cardiovascular Medicine|October 11, 2021
Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative StateGeorgios Louloudis, Samuele Ambrosini, Francesco Paneni, et al.
Frontiers in Cardiovascular Medicine|January 31, 2022
Corrigendum: Adeno-Associated Virus-Mediated Gain-of-Function mPCSK9 Expression in the Mouse Induces Hypercholesterolemia, Monocytosis, Neutrophilia, and a Hypercoagulative StateGeorgios Louloudis, Samuele Ambrosini, Francesco Paneni, et al.
Pageof 2